Related Experiment Video
Updated: Jul 14, 2026
07:08
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
In vitro short-term test evaluation of catecholestrogens genotoxicity
Damiano Rossi1, Vincenzo Aiello, Laura Mazzoni
1CAT Group, Centro Analisi Territoriali, via Provinciale 73, I 44030 Copparo (Ferrara), Italy. damiano.rossi@catgroup.info
Summary
Estrogens
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Estrogens are key factors in breast cancer development and progression, primarily through estrogen receptors mediating cell proliferation.
- A direct role for estrogens as tumor initiators is hypothesized, but their genotoxicity in breast cancer remains debated.
Purpose of the Study:
- To investigate the genotoxic activity of specific estrogen metabolites, including catecholestrogens and 16alpha-hydroxy estrone.
- To evaluate the genotoxic potential of these compounds using bacterial and human cell-based assays.
Main Methods:
- Salmonella Ames tests (strains TA98 and TA100) were performed.
- Sister Chromatid Exchange (SCE) assays were conducted.
- Micronucleus assays, including Cytochalasin B-induced Micronucleus (CBMN) and Aberrant cells/Micronucleus (ARA/CBMN) assays, were utilized on human peripheral lymphocytes.
Main Results:
- Micronucleus assays showed predominantly negative results, with 2-hydroxy estradiol (2-OHE(2)) exhibiting a unique concentration-dependent "bell-shaped" trend.
- The SCE assay indicated weak genotoxic activity for most tested catechol metabolites.
- 4-hydroxy estrone (4-OHE(1)) yielded negative results in both SCE and ARA/CBMN assays.
Conclusions:
- The study suggests weak genotoxicity of the investigated estrogen metabolites.
- The observed genotoxicity is not strongly correlated with the established carcinogenic potential of estrogens.
- Findings contribute to the ongoing discussion regarding the direct genotoxic role of estrogens in breast cancer initiation.
Related Concept Videos
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...